IHT Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

IHT Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,382	Closed	-$219K	–	994
2021 Q1	$219K	Sell	2,382 -5,686	-70%	-$480K	0.02%	739
2020 Q4	$590K	Buy	8,068 +635	+9%	+$47.2K	0.05%	357
2020 Q3	$577K	Buy	7,433 +23	+0.3%	+$1.58K	0.06%	318
2020 Q2	$412K	Buy	+7,410	New	+$317K	0.06%	328
2018 Q2	–	Sell	-5,150	Closed	-$71K	–	1583
2018 Q1	$71K	Hold	5,150	–	–	0.02%	584
2017 Q4	$80K	Buy	+5,150	New	+$72.3K	0.02%	555

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

IHT Wealth Management's HZNP Position: Q2 2021 in Review

IHT Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 2,382 shares — an estimated $219K sold.

IHT Wealth Management first reported a position in HZNP in Q4 2017 and held it in 6 quarters. The position peaked at $590K in Q4 2020. 527 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

IHT Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
IHT Wealth Management sold 2,382 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $219K.
IHT Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2017 and held it in 6 quarters.
IHT Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $590K in Q4 2020.
527 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on IHT Wealth Management's 13F filing for Q2 2021, filed 16 Aug 2021.